Certis Oncology Solutions
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5626 Oberlin Dr Ste 110, San Diego, Cali...Phone Number
(858) 952-1820Website
www.certisoncology.comRevenue
$10.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About Certis Oncology Solutions
Certis Oncology Solutions was formed in 2016 with the mission to provide individualized treatment options to cancer patients. Their technology enables oncologists to determine with precision the most effective available therapies to treat each patient's unique disease. Pharmaceutical companies leverage their expertise in precision oncology to obtain accurate, scientifically relevant data for preclinical decision-making. Findings from their science can dramatically improve lead optimization of new drug candidates, reduce development risk, and expedite the path to clinical trials.Explore more
Certis Oncology Solutions Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Certis Oncology Solutions your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Certis Oncology Solutions has new funding data
Check out if Certis Oncology Solutions is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Certis Oncology Solutions
Product Launch: Get notified when Certis Oncology Solutions launches new products
Earning: See what the market has to say on Certis Oncology Solutions recently announced quarterly report
Check if Certis Oncology Solutions has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Certis Oncology Solutions, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Certis Oncology Solutions had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Certis Oncology Solutions
Find 2 more new buyers
Compare Similar Companies to Certis Oncology Solutions
Compare insights from companies similar to Certis Oncology Solutions, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Certis Oncology Solutions
$10.5M
11-50
Private
$10M
2016
DH
Diana HornbergerDirector, Regulatory & Quality
Company Profile Activity
Activity Insights
Certis Oncology Solutions is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Certis Oncology Solutions is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Certis Oncology Solutions.
Certis Oncology Solutions financials insights
Gather financial insights about Certis Oncology Solutions, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series C
$10M
Certis Oncology Solutions Tech Stack
A closer look at the technologies used by Certis Oncology Solutions
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Machine Learning, Intellectual Property, Legal Affairs, Software, Artificial Intelligence
Funding
Open Position
Open Position
Certis Oncology Solutions News & Media
Certis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligence™ Platform
SAN DIEGO--(BUSINESS WIRE)-- #CertisAI--Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States Patent and Trademark Office (USPTO) has allowed a patent application directed to Certis’s predictive artificial intelligence/machine learning (AI/ML) platform, CertisAI™. “The patent marks an important milestone for our company,” said Peter Ellman, President and CEO of Certis. “It substantiates the uniqueness of our proprietary platformCertis Oncology Solutions President & CEO, Peter Ellman, Presents at the 24th Annual Precision World Medicine Conference
SAN DIEGO--(BUSINESS WIRE)-- #CertaintySavesLives--Certis President & CEO, Peter Ellman, Presents on Predictive Oncology Intelligence at the 24th Annual Precision World Medicine ConferenceCertis Oncology Solutions Unveils CertisOI Assistant™
SAN DIEGO--(BUSINESS WIRE)-- #CertaintySavesLives--Certis Oncology Solutions, a translational science and emerging technology leader in preclinical oncology research, is pleased to announce the commercial launch of CertisOI Assistant™, an innovative chatbot tool designed to enhance the efficiency and effectiveness of cancer research. This cutting-edge research tool leverages artificial intelligence/machine learning (AI/ML) and OpenAI’s ChatGPT language model to quickly provide researchers with uCertis Oncology Announces Closing of $10 Million Series C Fundraising Round
SAN DIEGO--(BUSINESS WIRE)-- #CertaintySavesLives--Certis Oncology Solutions (Certis), a precision oncology and translational science company focused on combining AI-directed drug development with advanced functional testing, today announced that it raised $10 million in a Series C funding round, bringing total raised to $42 million. The company also named John R. Tozzi Chairman of its Board of Directors. “We welcome John’s leadership and this additional investment at this critical inflection po
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Certis Oncology Solutions
Sign Up For FreeTo access detailed company insights
Certis Oncology Solutions was formed in 2016 with the mission to provide individualized treatment options to cancer patients. Their technology enables oncologists to determine with precision the most effective available therapies to treat each patient's unique disease. Pharmaceutical companies leverage their expertise in precision oncology to obtai... Read More
